HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing-Ping Liou Selected Research

Paclitaxel (Taxol)

5/2016MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
1/2013MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing-Ping Liou Research Topics

Disease

74Neoplasms (Cancer)
02/2024 - 06/2002
11Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 01/2012
10Glioblastoma (Glioblastoma Multiforme)
02/2024 - 10/2017
10Leukemia
05/2021 - 07/2010
6Hypoxia (Hypoxemia)
01/2019 - 07/2013
5Multiple Myeloma
01/2020 - 11/2017
4Glioma (Gliomas)
10/2022 - 11/2016
4Inflammation (Inflammations)
01/2022 - 07/2013
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 01/2014
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 05/2016
4Neoplasm Metastasis (Metastasis)
01/2019 - 12/2007
3Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2015
3Stomach Neoplasms (Stomach Cancer)
06/2021 - 10/2007
3Heart Failure
09/2014 - 10/2013
2Necrosis
01/2024 - 07/2004
2Pathologic Processes
01/2023 - 01/2012
2Brain Neoplasms (Brain Tumor)
01/2023 - 01/2021
2Body Weight (Weight, Body)
01/2022 - 10/2013
2Lung Neoplasms (Lung Cancer)
12/2021 - 07/2021
2Hematologic Neoplasms (Hematological Malignancy)
06/2021 - 01/2017
2Breast Neoplasms (Breast Cancer)
06/2020 - 01/2019
2Liver Neoplasms (Liver Cancer)
06/2020 - 03/2014
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 03/2015
2Lymphoma (Lymphomas)
01/2020 - 01/2013
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2018 - 07/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 05/2016
2Squamous Cell Carcinoma of Head and Neck
03/2018 - 01/2016
2Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 05/2016
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2018
2Colonic Neoplasms (Colon Cancer)
01/2017 - 01/2017
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 01/2016
2Hepatocellular Carcinoma (Hepatoma)
01/2016 - 03/2014
2Carcinoma (Carcinomatosis)
01/2016 - 07/2004

Drug/Important Bio-Agent (IBA)

22Histone Deacetylase InhibitorsIBA
08/2023 - 01/2012
17Histone Deacetylases (Histone Deacetylase)IBA
08/2023 - 01/2012
13Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2007
7Histone Deacetylase 6IBA
01/2021 - 05/2014
5Hydroxamic Acids (Hydroxamic Acid)IBA
02/2024 - 02/2017
53- (1- benzenesulfonyl- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA
01/2022 - 01/2012
5Antineoplastic Agents (Antineoplastics)IBA
10/2021 - 07/2004
5Histones (Histone)IBA
02/2020 - 07/2014
5TubulinIBA
01/2019 - 01/2013
4Temozolomide (Temodar)FDA LinkGeneric
02/2024 - 10/2017
4Protein Isoforms (Isoforms)IBA
02/2023 - 04/2018
4MPT0L145IBA
12/2021 - 05/2016
4ChromatinIBA
06/2021 - 07/2015
4Tubulin ModulatorsIBA
01/2018 - 01/2013
3Messenger RNA (mRNA)IBA
02/2022 - 07/2013
3quinolineIBA
12/2021 - 04/2017
3MPT0B291IBA
10/2021 - 01/2020
3EnzymesIBA
06/2021 - 10/2013
3entinostat (MS 275)IBA
06/2021 - 04/2020
3CaspasesIBA
05/2021 - 07/2004
3Vincristine (Oncovin)FDA LinkGeneric
04/2020 - 07/2015
3MPT0G211IBA
01/2019 - 01/2018
3MPT0B098IBA
03/2018 - 07/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2018 - 07/2010
3matrigelIBA
07/2015 - 07/2010
3Angiotensin IIIBA
09/2014 - 10/2013
3fosbretabulin (combretastatin A4)IBA
10/2007 - 06/2002
2antiglomerular basement membrane antibodyIBA
01/2024 - 05/2021
2Monoamine Oxidase (MAO)IBA
08/2023 - 10/2022
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2023 - 07/2015
2AntibodiesIBA
01/2023 - 09/2022
2compound 17IBA
01/2023 - 03/2020
2CytokinesIBA
01/2023 - 01/2012
2RNA-Binding Proteins (RNA-Binding Protein)IBA
02/2022 - 07/2013
2AfatinibIBA
07/2021 - 03/2020
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2021 - 01/2019
2N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
04/2021 - 06/2020
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 01/2017
2benzamideIBA
06/2020 - 01/2019
2B7-H1 AntigenIBA
03/2020 - 10/2019
2Oxygen (Dioxygen)IBA
01/2020 - 01/2017
2Therapeutic UsesIBA
01/2020 - 01/2012
2Ligases (Synthetase)IBA
01/2020 - 11/2017
2Bortezomib (Velcade)FDA Link
01/2019 - 01/2018
2Metalloproteases (Metalloproteinases)IBA
01/2019 - 01/2012
2Matrix Metalloproteinases (MMPs)IBA
01/2019 - 01/2012
2Cyclin B1IBA
01/2017 - 01/2013
2Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 01/2016
2BenzenesulfonamidesIBA
01/2017 - 08/2015
2VorinostatFDA Link
11/2016 - 07/2015
2Annexin A5IBA
05/2016 - 07/2004
2Propidium (Propidium Iodide)IBA
05/2016 - 07/2004
22- dimethylamino- N- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 7- yl)acetamideIBA
05/2016 - 01/2013
2Paclitaxel (Taxol)FDA LinkGeneric
05/2016 - 01/2013
2Antimitotic AgentsIBA
01/2016 - 07/2004
2compound 21IBA
08/2015 - 10/2013
2CarrageenanIBA
10/2014 - 07/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2014 - 10/2013
26- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indoleIBA
07/2010 - 07/2004
22,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanoneIBA
07/2004 - 06/2003
1abirateroneIBA
02/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024
1Donepezil (Aricept)FDA LinkGeneric
02/2023

Therapy/Procedure

23Therapeutics
01/2023 - 01/2014
3Drug Therapy (Chemotherapy)
12/2018 - 04/2017
2Oral Administration
04/2017 - 10/2007